Pfizer admits heart attack risk for Bextra.
->Read More...
On October 16, 2004, The New York times reported that Pfizer warned doctors about Bextra posing an increased risk of heart attack or stroke in coronary artery bypass surgery patients...
Bextra Heart Attacks.
->Read More...
Pfizer admits that the Cox-2 drug Bextra is linked to heart problems. Clinical trials showed heart bypass surgery patients taking Bextra, an anti-inflammatory in the same class as the recently withdrawn drug Vioxx, had a higher risk of stroke and heart attack...